聚合物分子包膜技术提高治疗效率:一篇评论
Jigar Vyas1, Nensi Raytthatha2, Bhupendra G Prajapati3
1Department of Pharmaceutics, Faculty of Pharmacy, Sigma University, Vadodara, Gujarat, 390019, India.
Current medicinal chemistry
|April 30, 2024
概括
聚合物分子包膜技术 (MET) 通过封装难溶性药物来增强药物输送和生物可用性. 这种创新方法提高了治疗疗效和药物稳定性.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 低水溶性限制了许多疏水药物的生物可用性和治疗效果.
- 聚合物分子外技术 (MET) 提供了一种新的策略来克服这些局限性.
研究的目的:
- 审查MET的应用,以提高治疗疗效.
- 探索使用MET改善药物输送和生物可用性的方法.
- 检查MET的制备,封装和治疗潜力.
主要方法:
- 对聚合物分子外技术现有文献的综述.
- 用于药物封装的基于循环德克斯的超分子组件的分析.
- 评估MET对药物的溶解性,稳定性和透性的影响.
主要成果:
- MET显著提高了水溶性较差的药物的可溶性和生物可用性.
- 在分子包裹中的封装可以保护药物免受降解.
- MET提高了通过生物膜的药物透性,从而改善了治疗结果.
结论:
- 聚合物分子外技术,特别是使用环氧素,是药物输送的变革性方法.
- MET具有优化治疗结果和推进制药科学的巨大潜力.
- 对MET应用的进一步研究可以打开新的治疗可能性.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Modified-Release Drug Delivery Systems: Overview
236
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
236
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K


